Literature DB >> 12150822

Focus on pancreas cancer.

Elizabeth M Jaffee1, Ralph H Hruban, Marcia Canto, Scott E Kern.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12150822     DOI： 10.1016/s1535-6108(02)00093-4

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  82 in total

1.  Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation.

Authors:  Indira Jutooru; Gayathri Chadalapaka; Ping Lei; Stephen Safe
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

Review 2.  NF-kappaB in pancreatic cancer.

Authors:  Guido M Sclabas; Shuichi Fujioka; Christian Schmidt; Douglas B Evans; Paul J Chiao
Journal:  Int J Gastrointest Cancer       Date:  2003

3.  Characterization of the CXCR4 signaling in pancreatic cancer cells.

Authors:  Daniel D Billadeau; Subrha Chatterjee; Patricia Bramati; Raghavakaimal Sreekumar; Vijay Shah; Karen Hedin; Raul Urrutia
Journal:  Int J Gastrointest Cancer       Date:  2006

4.  Expression of oncogenic K-ras and loss of Smad4 cooperate to induce the expression of EGFR and to promote invasion of immortalized human pancreas ductal cells.

Authors:  Shujie Zhao; Yubao Wang; Lin Cao; Michel M Ouellette; James W Freeman
Journal:  Int J Cancer       Date:  2010-11-01       Impact factor: 7.396

5.  Transforming mutations of RAC guanosine triphosphatases in human cancers.

Authors:  Masahito Kawazu; Toshihide Ueno; Kenji Kontani; Yoshitaka Ogita; Mizuo Ando; Kazutaka Fukumura; Azusa Yamato; Manabu Soda; Kengo Takeuchi; Yoshio Miki; Hiroyuki Yamaguchi; Takahiko Yasuda; Tomoki Naoe; Yoshihiro Yamashita; Toshiaki Katada; Young Lim Choi; Hiroyuki Mano
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

6.  The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.

Authors:  Brian C Lewis; David S Klimstra; Harold E Varmus
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

7.  Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II.

Authors:  Lisa M Oppegard; Andrei V Ougolkov; Doris N Luchini; Renee A Schoon; John R Goodell; Harneet Kaur; Daniel D Billadeau; David M Ferguson; Hiroshi Hiasa
Journal:  Eur J Pharmacol       Date:  2008-12-03       Impact factor: 4.432

Review 8.  TGFbeta in Cancer.

Authors:  Joan Massagué
Journal:  Cell       Date:  2008-07-25       Impact factor: 41.582

9.  Structure-dependent activation of endoplasmic reticulum stress-mediated apoptosis in pancreatic cancer by 1,1-bis(3'-indoly)-1-(p-substituted phenyl)methanes.

Authors:  Ping Lei; Maen Abdelrahim; Sung Dae Cho; Xinyi Liu; Xingi Liu; Stephen Safe
Journal:  Mol Cancer Ther       Date:  2008-10       Impact factor: 6.261

10.  Regulation of pancreatic tumor cell proliferation and chemoresistance by the histone methyltransferase enhancer of zeste homologue 2.

Authors:  Andrei V Ougolkov; Vladimir N Bilim; Daniel D Billadeau
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.